cholesterol embolismrenal arteriesacute renal failurecoronaroangiographyglucocorticosteroidхолестериновая эмболияпочечные артерииострая почечная недостаточностькоронароангиографияглюкокортикостероид1.Bakris G. L., Lass N., Gaber А. О. et al. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am. J. Physiol. 1990; 258: F115-F120.2.Briguori C., Manganelli F., Scarpato P. et al. Acetylcysteine and contrast-agent nephrotoxicity. J. Am. Coll. Cardiol. 2002; 40: 298-303.3.Darger L. F., Andrade L., Barros De Toledo J. F. et al. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol. Dial. Transplant. 2004; 19: 1803-1807.4.Murphy S. W., Barret B. J., Parfrey P. S. Contrast nephropathy. J. Am. Soc. Nephrol. 2000; 11: 177-182.5.Mayo R. R., Swartz R. D. Redefining the incidence of clinically detectable atheroembolism. Am. J. Med. 1996; 100 (5): 524-529.6.Thadhani R. I., Camargo C. A., Xavier R. J. et al. Atheroembolic renal failure after invasive procedures. Natural history based on 52 histologically proven cases. Medicine (Baltimore) 1995; 74 (6): 350-358.7.Modi K. S., Rao V. K. Atheroembolic renal disease. J. Am. Soc. Nephrol. 2001; 12: 1781-1787.8.Jones D. В., Iannaccone P. M. Atheromatous emboli in renal biopsies. Am. J. Pathol. 1975; 78: 261-271.9.Ribera Pibernat M., Bigatä Viscasillas X., Fuentes Gonzälez M. J. et al. Cholesterol embolism disease: study of 16 cases. Rev. Clin. Esp. 2000; 200 (12): 659-663.10.Fine M. J., Kapoor W., Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology 1987; 38 (10): 769-784.11.Stabellini N., Cerretani D., Russo G. et al. Renal atheroembolic disease: evaluation of the efficacy of corticosteroid therapy. G. Ital. Nefrol. 2002; 19 (1): 18-21.12.Tanaka M., Matsuo K., Shoda H. et al. Severe hyperreninemic hypertension associated with spontaneous renal cholesterol crystal embolization. Clin. Exp. Nephrol. 2004; 8 (2): 150-154.13.Kasinath B. S., Lewis E. J. Eosinophilia as a clue to the diagnosis of atheroembolic renal disease. Arch. Intern. Med. 1987; 147: 1384-1385.14.Wilson D. M., Salazer T. L., Farkouh M. E. Eosinophiluria in atheroembolic renal disease. Am. J. Med. 1991; 91 (2): 186-189.15.Greenberg A., Bastacky S. I., Iobal A. et al. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations. Am. J. Kidney Dis. 1997; 29: 334-344.16.Goldman M., Thoua Y., Dhaene M., Toussaint C. Necrotising glomerulonephritis associated with cholesterol microemboli. Br. Med. J. 1985; 290: 205-206.17.Aviles В., Ubeda I., Blanco J., Barrientos A. Pauci-immune extracapillary glomerulonephritis and atheromatous embolization. Am. J. Kidney Dis. 2002; 40 (4): 847-851.18.Hasegawa M., Kawashima S., Shikano M. et al. The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. A report of 5 cases. Am. J. Nephrol. 2000; 20 (4): 263-267.19.Yücel A. E., Kart-Köseoglu H., Demirhan В., Ozdemir F. N. Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases. Rheumatol. Int. 2006; 26 (5): 454-460.20.Cabili S., Teachman I., Goor Y. Reversal of gangrenous lesions in the blue toe syndrome with lovastatin - a case report. Angiology 1993; 44: 821-825.21.Woolfson R. G., Lachman H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet 1998; 351: 1331-1332.22.Chade A. R., Zhu X., Mushin O. P. et al. Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. FASEB J. 2006; 20 (10): 1706-1708.23.Massy Z. A., Guijarro C. Statins: effects beyond cholesterol lowering. Nephrol. Dial. Transplant. 2001; 16: 1738-1741.24.Vidt D. G., Eisele G., Gephardt G. N. et al. Atheroembolic renal disease: association with renal arterial stenosis. Cleveland Clin. J. Med. 1989; 56 (4): 407-413.25.Rupprecht H. Postinterventional cholesterol crystal embolization. Dtsch. Med. Wschr. 2007; 132 (36): 1833-1836.26.Charytan D. M., Marulkar S. Relationship of aortic atherosclerosis to acute renal failure following cardiac surgery. J. Nephrol. 2006; 19 (5): 628-633.27.Fuks D. F., Griguoli R. E., Borracci R. A., Sala C. Cholesterol embolization following coronary angioplasty. Rev. Port. Cardiol. 1992; 11 (12): 1089-1091.28.Funabiki K., Masuoka H., Shimizu H. et al. Cholesterol crystal embolization (CCE) after cardiac catheterization: a case report and a review of 36 cases in the Japanese literature. Jpn. Heart J. 2003; 44 (5): 767-774.29.Gerke R., Fahrenkrog U., Löllgen H. Cholesterol-crystal embolization after PTCA. Case report and review of the literature. Med. Klin. 2003; 98 (7): 388-393.30.Nakamoto S., Kaneda Т., Inoue T. et al. Disseminated cholesterol embolism after coronary artery bypass grafting. J. Card. Surg. 2001; 16 (5): 410-413.31.Brunner M., Trebing D., Göring H. D. Cholesterol embolism syndrome after coronary angiography. Hautarzt 2005; 56 (9): 854-859.32.Scolari F., Tardanico R., Zani R. et al. Cholesterol crystal embolism: A recognizable cause of renal disease. Am. J. Kidney Dis. 2000; 36 (6): 1089-1109.33.Saklayen M. G., Gupta S., Suryaprasad A., Azmeh W. Incidence of atheroembolic renal failure after coronary angiography. A prospective study. Angiology 1997; 48 (7): 609-613.34.Thériault J., Agharazzi M., Dumont M. et al. Atheroembolic renal failure requiring dialysis: potential for renal recovery? A review of 43 cases. Nephron Clin. Pract. 2003; 94 (1): с11-с18.35.Hyman В. Т., Landas S. К., Ashman R. F. et al. Warfarin-related purple toes syndrome and cholesterol microembolization. Am. J. Med. 1987; 82: 1233-1237.36.Feder W., Auerbach R. "Purple toes": an uncommon sequela of oral coumadin drug therapy. Ann. Intern. Med. 1961; 55: 911-917.37.Schwartz M. W., McDonald G. B. Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction. J. A. M. A. 1987; 258 (14): 1934-1935.38.Wong F. K., Chan S. K., Ing T. S. et al. Acute renal failure after streptokinase therapy in a patient with acute myocardial infarction. Am. J. Kidney Dis. 1995; 26 (3): 508-510.39.Hitti W. A., Anderson J. Cholesterol emboli-induced renal failure and gastric ulcer after thrombolytic therapy. South. Med. J. 2005; 98 (2): 235-237.40.Gupta В. K., Spinowitz B. S., Charytan C, Wahl S. J. Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator. Am. J. Kidney Dis. 1993; 21 (6): 659-662.41.Gallego Page J. C, Gömez Honrubia M. C, Gallardo Löpez A. et al. Skin lesions and renal failure after myocardial infarction. Rev. Esp. Cardiol. 2001; 54 (11): 1339-1342.42.Fukumoto Y., Tsutsui H., Tsuchihashi M. Cholesterol Embolism Study (CHEST) Investigators. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J. Am. Coll. Cardiol. 2003; 42 (2): 211-216.43.Kazancioglu R., Erkoc R., Bozfakioglu S. et al. Clinical outcomes of renal cholesterol crystal embolization. J. Nephrol. 1999; 12 (4): 266-269.44.Lye W. C., Cheah J. C., Sinniah R. Renal cholesterol embolic disease. Am. J. Nephrol. 1993; 13: 489-493.45.Hara S., Asada Y., Fujimoto S. et al. Atheroembolic renal disease: clinical findings of 11 cases. J. Atheroscler. Thromb. 2002; 9 (6): 288-291.46.Lai С. K., Randhawa P. S. Cholesterol embolization in renal allografts: a clinicopathologic study of 12 cases. Am. J. Surg. Pathol. 2007; 31 (4): 536-545.47.Scolari F., Tardanico R., Pola A. et al. Cholesterol crystal embolic disease in renal allografts. J. Nephrol. 2003; 16 (1): 139-143.